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Abstract
Background: Cigarette smoke (CS) is a major risk factor for the development of COPD. CS exposure is associated
with an increased risk of bacterial colonization and respiratory tract infection, because of suppressed antibacterial
activities of the immune system and delayed clearance of microbial agents from the lungs. Colonization with
Staphylococcus aureus results in release of virulent enterotoxins, with superantigen activity which causes T cell
activation.
Objective: To study the effect of Staphylococcus aureus enterotoxin B (SEB) on CS-induced inflammation, in a
mouse model of COPD.
Methods: C57/Bl6 mice were exposed to CS or air for 4 weeks (5 cigarettes/exposure, 4x/day, 5 days/week).
Endonasal SEB (10 μg/ml) or saline was concomitantly applied starting from week 3, on alternate days. 24 h after
the last CS and SEB exposure, mice were sacrificed and bronchoalveolar lavage (BAL) fluid and lung tissue were
collected.
Results: Combined exposure to CS and SEB resulted in a raised number of lymphocytes and neutrophils in BAL, as
well as increased numbers of CD8+ T lymphocytes and granulocytes in lung tissue, compared to sole CS or SEB
exposure. Moreover, concomitant CS/SEB exposure induced both IL-13 mRNA expression in lungs and goblet cell
hyperplasia in the airway wall. In addition, combined CS/SEB exposure stimulated the formation of dense,
organized aggregates of B- and T- lymphocytes in lungs, as well as significant higher CXCL-13 (protein, mRNA) and
CCL19 (mRNA) levels in lungs.
Conclusions: Combined CS and SEB exposure aggravates CS-induced inflammation in mice, suggesting that
Staphylococcus aureus could influence the pathogenesis of COPD.
Background
Cigarette smoking is associated with an increased risk of
bacterial colonization and respiratory tract infection,
because of suppressed antibacterial activities of the
immune system and delayed clearance of microbial
agents from the lungs [1]. This is particularly relevant in
COPD patients, where bacterial colonization in the
lower respiratory tract has been shown [2]. These
bacteria are implicated both in stable COPD and during
exacerbations, where most commonly pneumococci,
Haemophilus influenza, Moraxella catarrhalis and Sta-
phylococcus aureus (S. aureus) are found [3]. Interest-
ingly, colonization with S. aureus may embody a major
source of superantigens as a set of toxins are being pro-
duced including S. aureus enterotoxins (SAEs) [4].
These toxins activate up to 20% of all T cells in the
body by binding the human leukocyte antigen (HLA)
class II molecules on antigen-presenting cells (APCs)
and specific V beta regions of the T cell receptor [5].
Between 50 and 80% of S. aureus isolates are positive
for at least one superantigen gene, and close to 50% of
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these isolates show superantigen production and toxin
activity [6].
During the last few years, it became increasingly clear
that SAEs are known to modify airway disease [7], like
allergic rhinitis [8], nasal polyposis [9] and asthma [10].
Furthermore, studies have shown a putative role for
SAEs in patients suffering from the atopic eczema/der-
matitis syndrome (AEDS), where colonization with S.
aureus is found more frequently (80-100%) compared to
healthy controls (5-30%) [11], and S. aureus isolates
secrete identifiable enterotoxins like Staphylococcus aur-
eus enterotoxin A and B (SEA, SEB) and toxic shock
syndrome toxin (TSST)-1. Until now, evidence for SAE
involvement in the pathogenesis of upper airway disease
like chronic rhinosinusitis with nasal polyposis
(CRSwNP), arises from the finding that IgE against SEA
and SEB has been demonstrated in nasal polyps [12]
and levels of SAE-specific IgE in nasal polyposis corre-
lated with markers of eosinophil activation and recruit-
ment [13]. Similarly, in COPD patients, a significantly
elevated IgE to SAE was found, pointing to a possible
disease modifying role in COPD, similar to that in
severe asthma [14]. Moreover, we have recently demon-
strated the pro-inflammatory effect of SEB on human
nasal epithelial cells in vitro, resulting in augmented
granulocyte migration and survival [15].
In murine research, the role of SAEs as inducer and
modifier of disease has been demonstrated in models of
airway disease [16,17], allergic asthma [18], atopic der-
matitis [19] and food allergy [20]. These findings high-
light the important pathological consequences of SAE
exposure, as these superantigens not only cause massive
T-cell stimulation, but also lead to activation of B-cells
and other pro-inflammatory cells like neutrophils, eosi-
nophils, macrophages and mast cells [21].
To date, the exact pathomechanisms of COPD are not
yet elucidated. Cigarette smoking is a primary risk factor
for the development of COPD, but only 20% of smokers
actually develop the disease, suggesting that genetic pre-
disposition plays a role [22]. However, understanding
the impact of toxin-producing bacteria on cigarette-
smoke induced inflammation might provide novel
insights into the pathogenesis of smoking-related disease
such as COPD. Therefore, we investigated the effects of
concomitant Staphylococcus aureus Enterotoxin B (SEB)
application on a well established mouse model of cigar-
ette-smoke (CS) induced inflammation [23]. We evalu-
ated inflammatory cells and their mediators in
bronchoalveolar lavage (BAL) fluid and lung tissue,
looked at systemic effects by measuring serum immuno-
globulins, and evaluated goblet cell hyperplasia and lym-
phoid neogenesis.
Methods
Experimental protocol
Male C57BL/6 mice (n = 8), 6-8 weeks old were pur-
chased from Charles River Laboratories (Brussels, Bel-
gium). Mice were exposed to the tobacco smoke of five
cigarettes (Reference Cigarette 2R4F without filter, Uni-
versity of Kentucky, Lexington, KY, USA) four times per
day with 30 min smoke-free intervals [24]. The animals
were exposed to mainstream cigarette smoke (CS) by
whole body exposure, 5 days per week for 4 weeks. Con-
trol groups (8 age-matched male C57BL/6 mice) were
exposed to air. Starting from day 14 of the CS exposure,
mice received concomitant endonasal application of SEB
(50 μL - 10 μg/mL - Sigma-Aldrich, LPS content below
detection limit) or Saline, on alternate days. This dose
was chosen based on Hellings et al. [18] For the applica-
tion, mice were slightly anaesthetized with isoflurane,
and six applications were performed as depicted in Figure
1. All experimental procedures were approved by the
local ethical committee for animal experiments (Faculty
of Medicine and Health Sciences, Ghent University). The
results section contains data from one representative
experiment out of three independent experiments.
Bronchoalveolar lavage and cytospins
Twenty-four hours after the last cigarette smoke (CS)
exposure and endonasal application, mice were sacri-
ficed by a lethal dose of pentobarbital (Sanofi-Synthe-
labo). A cannula was inserted in the trachea, and BAL
was performed by instillation of 3 × 300 μl of HBSS
supplemented with BSA for cytokine measurements.
Three additional instillations with 1 ml of HBSS plus
EDTA were performed to achieve maximal recovery of
BAL cells. A total cell count was performed in a Bürker
chamber. Approximately fifty thousand BAL cells were
processed for cytospins and were stained with May-
Grünwald-Giemsa for differential cell counting. The
remaining cells were used for FACS analysis.
Day d25: endpoint0 7 14 16 18 20 22 24
Smoke/Air
SEB/SAL
Figure 1 Experimental protocol. Male C57BL/6 mice (n = 8) were
exposed to cigarette smoke(CS) of five cigarettes, four times per
day with 30 min smoke-free intervals. Controls were exposed to air.
Starting from day 14 of the CS exposure, mice received
concomitant endonasal application of SEB (50 μL - 10 μg/mL) or
saline, on alternate days.
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Preparation of lung single-cell suspensions
Blood was collected via retro-orbital bleeding. Then, the
pulmonary and systemic circulation was rinsed to
remove contaminating blood cells. Lungs were taken
and digested as described previously [24]. Briefly,
minced lung pieces were incubated with 1 mg/ml col-
lagenase and 20 μg/ml DNase I for 45 min at 37°C. Red
blood cells were lysed using ammonium chloride buffer.
Finally, cell suspensions were filtered through a 50-μm
nylon mesh to remove undigested organ fragments.
Flow cytometry
All staining procedures were conducted in calcium- and
magnesium-free PBS containing 10 mM EDTA, 1% BSA
(Dade Behring), and 0.1% sodium azide. Cells were pre-
incubated with anti-CD16/CD32 (2.4G2) to block Fc
receptors. Antibodies used to identify mouse DC popu-
lations were anti-CD11c-allophycocyanin (APC; HL3)
and anti-I-Ab-phycoerythrin (PE; AF6-120.1). The fol-
lowing mAbs were used to stain mouse T-cell subpopu-
lations: anti-CD4-fluorescein isothiocyanate (FITC;
GK1.5), anti-CD8-FITC (53-6.7), anti-CD3-APC (145-
2C11) and anti-CD69-PE (H1.2F3). To identify granulo-
cytes, anti-Gr-1-PE (RB6-8C5) and anti-CD11c-APC
(HL3) were used. As a last step before analysis, cells
were incubated with 7-aminoactinomycin D (or viap-
robe; BD Pharmingen) for dead cell exclusion. All label-
ing reactions were performed on ice in FACS-EDTA
buffer. Flow cytometry data acquisition was performed
on a FACScalibur™ running CellQuest™ software (BD
Biosciences, San Jose, CA, USA).
Measurement of Immunoglobulins
Retro-orbital blood was drawn for measurement of total
IgE, IgG, IgM and IgA with ELISA. Commercially avail-
able ELISA kits were used to determine serum and BAL
titers of IgG (ZeptoMetrix, Buffalo, NY, USA), IgM
(ZeptoMetrix, Buffalo, NY, USA) and IgA (Alpha Diag-
nostic International, San Antonio, TX, USA). For the
measurement of total IgE, a two-side in-house sandwich
ELISA was used, with two monoclonal rat anti-mouse
IgE antibodies reacting with different epitopes on the
epsilon heavy chain (H. Bazin, Experimental Immunol-
ogy Unit, UCL, Brussels, Belgium). The second antibody
was biotinylated and detected colorimetrically after add-
ing horseradish peroxidase-streptavidine conjugate.
Absorbance values, read at 492 nm (Labsystems Multi-
scan RC, Labsystems b.v., Brussels, Belgium) were con-
verted to concentrations in serum and BAL fluid by
comparison with a standard curve obtained with mouse
IgE of known concentration (H. Bazin)
Goblet cell analysis
Left lung was fixed in 4% paraformaldehyde and
embedded in paraffin. Transversal sections of 3 μm
were stained with periodic acid-Schiff (PAS) to identify
goblet cells. Quantitative measurements of goblet cells
were performed in the airways with a perimeter of base-
ment membrane (Pbm) ranging from 800 to 2000 μm.
Results are expressed as the number of goblet cells per
millimeter of basement membrane.
Morphometric quantification of lymphoid neogenesis
To evaluate the presence of lymphoid infiltrates in lung
tissues, sections obtained from formalin-fixed, paraffin-
embedded lung lobes were subjected to an immunohis-
tological CD3/B220 double-staining as described pre-
viously [24]. Infiltrates in the proximity of airways and
blood vessels were counted. Accumulations of ≥50 cells
were defined as lymphoid aggregates. Counts were nor-
malized for the number of bronchovascular bundles per
lung section.
RT-PCR analysis
Total lung RNA was extracted with the Rneasy Mini kit
(Qiagen, Hilden, Germany). Expression of CXCL-13,
CCL19, IL-13 and MIP-3a mRNA relative to HPRT
mRNA [25], were performed with Assay-on-demand
Gene Expression Products (Applied Biosystems, Foster
City, CA, USA). Real-time RT PCR for CCL21-leucine
and CCL21-serine started from 25 ng of cDNA. Primers
and FAM/TAMRA probes were synthesized on demand
(Sigma-Proligo). Primer/probe sequences and PCR con-
ditions were performed as described previously [26,27].
Protein measurement in BAL
CXCL13 protein levels in BAL supernatant were deter-
mined using a commercially available ELISA (R&D Sys-
tems, Abingdon, UK). Cytometric Bead Array (BD
Biosciences, San Jose, CA, USA) was used to detect the
cytokines KC, MCP-1, IL-17A and IFN-g in the superna-
tant of BAL fluid.
Statistical analysis
Reported values are expressed as mean ± SEM. Statisti-
cal analysis was performed with SPSS software (version
18.0) using nonparametric tests. The different experi-
mental groups were compared by a Kruskal-Wallis test
for multiple comparisons. When a p-value ≤ 0.05 was
obtained with the Kruskal-Wallis test, pairwise compari-
sons were made by means of a Mann-Whitney U test
with Bonferroni corrections for multiple comparisons. A
p-value p ≤ 0.05 was considered significant.
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Results
SEB aggravates the CS-induced pulmonary inflammation
To evaluate the effects of Staphylococcus aureus entero-
toxin B (SEB) on cigarette smoke (CS)-induced pulmon-
ary inflammation, C57Bl/6 mice were exposed to CS for
4 weeks, with a concomitant SEB exposure during the
last 2 weeks (Figure 1).
In BAL fluid, sole endonasal SEB application and sole
CS-exposure resulted in increased numbers of total
cells, alveolar macrophages, dendritic cells (DCs), lym-
phocytes and neutrophils, compared to air/saline
exposed animals (Figure 2A-E). However, these increases
in cell numbers were much more pronounced upon SEB
application compared to CS-exposure. Also a modest
eosinophilic inflammation was observed in the SEB-
exposed groups (Figure 2F).
Interestingly, the combination of CS exposure and
SEB significantly increased BAL neutrophil numbers
compared to sole CS or SEB exposure (Figure 2E). Also
BAL lymphocyte numbers in smoke-exposed mice were
increased upon SEB application (Figure 2D).
In lung single cell suspensions, SEB solely induced an
increase in DCs, CD3+ T cells and macrophages,
whereas CS exposure caused increased DCs and CD3+
T cells in lung tissue (Figure 3A, D, B).
Interestingly, combined CS and SEB exposure caused
a further increase in CD3+ T cells, and more specifically
CD8+ T-cells, compared to CS or SEB alone (Figure 3D,
F). Also DC, CD4+ T-cells and GR1+ cells tended to be
higher in the combined CS/SEB group versus sole CS or
SEB application (Figure 3A, E, C).
Increased IL-17A in BAL upon combined SEB and CS
exposure
As previously described [24], 4-wk CS-exposure clearly
induced high levels of KC (mouse homolog for IL-8)
and MCP-1 in BAL (Figure 4A, B). In contrast sole SEB
application induced a modest increase in KC, and very
low levels of IFN-g and IL-17A (Figure 4A, D, C).
Whereas the CS-induced KC and MCP-1 levels in BAL
were not affected by an additional SEB exposure, the
combined CS and SEB exposure did induce IL-17A
levels in BAL, compared to single CS or SEB exposure
(Figure 4C). Also IFN-g levels tended to be highest in
the combined CS/SEB group (Figure 4D).
mRNA levels of MIP-3a were increased after both CS
or SEB exposure. Combined CS/SEB exposure did not
cause a further MIP-3a increase (Figure 4E).
SEB induces IgA and IgM levels in BAL
Systemic effects of either CS or SEB, or both were eval-
uated in serum, but no significant differences in total
IgG, IgM, IgA or IgE levels were detected between the
experimental groups. In BAL, CS exposure tended to
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Figure 2 BAL fluid analysis. Total BAL cells and cell differentiation in BAL fluid of mice exposed to saline or SEB, combined with air or CS. A)
Total BAL cells, B) macrophages, C) dendritic cells, D) lymphocytes, E) neutrophils, F) eosinophils. Results are expressed as mean ± SEM, n = 8
animals/group, *p < 0.05, **p < 0.01.
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Figure 3 Lung cell differentiation. Flow cytometric analysis of cells from lung digest: A) dendritic cells, B) macrophages, C) GR1+ cells, D) CD3+
T lymphocytes, E) CD4+ T lymphocytes and F) CD8+ T lymphocytes from mice exposed to saline or SEB, combined with air or CS. Results are
expressed as mean ± SEM, n = 8 animals/group, *p < 0.05.
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Figure 4 Protein measurements in BAL fluid. Protein levels of A) KC, B) MCP-1, C) IL-17A, D) IFN-g in BAL fluid of mice exposed to saline or
SEB, combined with air or CS, as measured with ELISA. E) mRNA expression of MIP-3a in total lung tissue, measured by RT-PCR. The results are
expressed as ratio with hypoxanthine guanine phosphoribosyltransferase (HPRT) mRNA. Results are expressed as mean ± SEM, n = 8 animals/
group, *p < 0.05, **p < 0.01.
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increase IgA. Both IgA and IgM levels in BAL were sig-
nificantly increased upon SEB-exposure (Figure 5). IgE
in BAL was below the detection limit.
Combined CS/SEB exposure affects epithelial remodeling
Epithelial remodeling was evaluated by counting the
number of PAS-positive goblet cells per millimeter of
basement membrane. A strong tendency towards
increased numbers of goblet cells in the CS/SEB mice
was observed, compared to all other conditions (Figure
6A, B). This finding correlated nicely with a significant
increase in IL-13 mRNA expression in total lung in CS/
SEB mice (Figure 6C).
Combined CS/SEB induces the formation of dense
lymphoid aggregates in lung tissue
Previously, our group has demonstrated increased lym-
phoid neogenesis after 6 months of CS-exposure [25].
As earlier shown in the CS-model, subacute CS-expo-
sure as such did not result in lymphoid neogenesis.
Interestingly however, already after 4-wk CS-exposure,
dense, organized lymphoid aggregates could be demon-
strated in the combined CS/SEB group whereas air/SEB
mice displayed mainly loose, non-organized lymphoid
aggregates (Figure 7).
Since CXCL13, CCL19 and CCL21 are chemokines
involved in the homeostatic trafficking of leukocytes,
mainly lymphocytes, to the secondary and tertiary lym-
phoid tissues, their expression was also evaluated in this
model. The increase in dense lymphoid aggregates in
CS/SEB mice correlated nicely with significant increases
in CXCL13 (protein levels in BAL fluid, mRNA levels in
total lung) (Figure 8A, B) and CCL19 (mRNA levels)
expression in CS/SEB mice compared to all other
groups (Figure 8E). CCL21 mRNA levels (both isoforms
CCL21-Ser and CCL21-Leu) decreased upon CS
exposure, confirming previous findings of CCL21 down-
regulation upon subacute CS exposure [26] and
decreased even further in the CS/SEB group. Intrigu-
ingly, the CCL21 mRNA levels of both isoforms tended
to increase upon sole SEB exposure (Figure 8C, D).
Discussion
We hereby describe a novel mouse model of combined
Staphylococcus aureus enterotoxin B (SEB) application
and cigarette smoke exposure, which results in a signifi-
cant aggravation of key features of CS-induced pulmon-
ary inflammation, such as neutrophils and CD8+ T cells
in BAL and lung. Furthermore, levels of IL-17A in BAL
were significantly increased upon concomitant SEB and
CS exposure, compared to sole exposures of SEB or CS.
In addition, tendencies of increased goblet cell hyperpla-
sia, IL-13 mRNA expression and lymphoid neogenesis
in smoke/SEB mice have been demonstrated, as well as
increased expression of the relevant chemokines
CXCL13 and CCL19. Altogether, these findings point to
a possible disease-modifying role for SEB in CS-induced
inflammation in this mouse model of subacute CS
exposure.
Increasing evidence from human and murine research
suggests that SEB is able to aggravate underlying dis-
ease. Moreover, SEB itself is also able to induce inflam-
mation, depending on the dosage and timing of the
experimental protocol [16,19]. Interestingly, these find-
ings are not confined to SEB, as other staphylococcal
superantigens demonstrate similar effects upon mucosal
contact [28,29]. In line with previously reported findings,
in our model sole endonasal SEB application caused an
increase in total BAL cell number, lymphocytes and
neutrophils [16]. Moreover, we could demonstrate raised
numbers of macrophages and dendritic cells, a finding
previously reported after S. aureus enterotoxin A
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exposure [28,29]. In the latter studies however, the
authors could not demonstrate increased eosinophils,
which was the case in our model. The superantigen
effect of SEB caused the expected lymphocyte accumula-
tion in BAL, which appeared to be non-specific, as both
CD4+ and CD8+ T cells were increased. These data
stress the potency of staphylococcal superantigens of
initiating a massive immune response.
Concomitant CS/SEB exposure lead to a remarkable
increase in neutrophil number, compared to CS or SEB
exposure alone. Although the findings for neutrophils in
lung (measured with granulocyte marker GR-1) were
less convincing than in BAL, the combined CS/SEB
group showed the highest number of GR-1+ cells. Inter-
estingly, also the CD8+ T cell fraction in lung single cell
suspensions, was significantly upregulated when smoke
and SEB were combined. The potential clinical relevance
of increased neutrophil and CD8+ T-cell numbers lays
in the fact that neutrophilic inflammation in the airways
in smokers correlates with an accelerated decline in
lung function [30], and increased T-cell numbers corre-
late with the amount of alveolar destruction and the
severity of airflow obstruction [31].
We confirm an increased MIP-3a expression in lungs
after CS exposure leading to an accumulation of dendri-
tic cells in this model [24]. Interestingly, this increase in
MIP-3a is also seen after SEB exposure, with raised
DCs in BAL and airway parenchyma in these groups.
As previously demonstrated in the subacute CS-model,
we have observed an increase in levels of KC and MCP-
1 after 4-wk CS exposure [24], explaining the accumula-
tion of inflammatory cells in BAL and lung. Sole SEB
application on the other hand resulted in raised levels of
KC, IFN-g and IL-17A, but not MCP-1. Interestingly,
the combined exposure of smoke and SEB further
increased the IL-17A levels, which might explain the
exacerbated BAL neutrophilia in CS/SEB mice. Indeed,
IL-17 is known to be important in neutrophil
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Figure 6 Epithelial remodeling. A) Histological evaluation of goblet cell hyperplasia on Periodic Acid Schiff (PAS) stained lung tissue sections of
mice exposed to saline or SEB, combined with air or CS. B) Quantification of goblet cells. C) mRNA expression of IL-13, relative to a
housekeeping gene (HPRT) was measured on total lung homogenates by RT-PCR. Results are expressed as mean ± SEM, n = 8 animals/group, *p
< 0.05.
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maturation, migration and function in the lung tissue
and airways. Furthermore, IL-17 induction of neutrophil
activation and migration is important in defense against
organisms infecting the lung [32]. Interestingly, IL-17
can also induce eosinophilic accumulation, in particular
circumstances [33].
IL-17 is normally produced by CD4+ T cells, although
it might also arise from CD8+ T cells and in some cases
even from macrophages, neutrophils or eosinophils [34],
as a necessary step in the normal immunity against bac-
terial infections in the airways. However, IL-17 has been
linked to unfavorable outcome to infection, in particular
in the presence of IFN-g [35], resulting a high inflamma-
tory pathology and tissue destruction. Increasing evi-
dence dedicates a role to exaggerated recruitment and
activation of neutrophils in the clinical course of airway
diseases like COPD. Therefore, it is tempting to specu-
late on a role for SEB in the induction of IL-17 release,
leading to the aggravation of cigarette smoke-induced
inflammation, with increased number and activation of
neutrophils, which causes amplification of tissue
destruction and subsequent disease progression.
In addition, we could observe already after 4-wks an
increase in the number of dense lymphoid aggregates in
CS/SEB mice, linked to increased levels of CXCL13 and
CCL19, which are attractants for B- and T-cells respec-
tively. Moreover, it has been described that the respec-
tive receptors for these chemokines - CXCR5 and CCR7
- are also expressed on Th17 cells migrating into
inflamed tissue [36], indicating a potential contribution
of IL17-producing Th17 cells in this model of early
COPD. The finding that lymphoid aggregates and the
chemokines responsible for their neogenesis and organi-
zation [25] are already upregulated after 4-wk CS/SEB
exposure, stresses the clinical relevance of this novel
model of combined CS and enterotoxin exposure.
Staphylococcal superantigens are able to cause massive
polyclonal T and B cell proliferation. Upon local applica-
tion, as is done in this model, this leads to the mucosal
synthesis of immunoglobulins, explaining the observed
increase in BAL IgA and IgM. In humans, it is thought
that continuous microbial stimulation leads to B cell turn-
over and plasma cell formation in nasal polyp disease,
leading to an overproduction of immunoglobulins [37].
In this mouse model of early stage COPD with goblet
cell hyperplasia and increased number of lymphoid folli-
cles, endonasal SEB application has resulted in augmen-
ted CS-induced lower airway inflammation. CS and
subsequent bacterial colonization are, amongst others,
factors believed to determine both progression of
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Figure 7 Evaluation of lymphoid aggregates in lung tissue. A) Photomicrographs of lymphoid aggregates in CD3/B220 immuno-stained
lung tissue of mice exposed to saline or SEB, combined with air or CS (brown: CD3 positive cells; blue: B220 positive cells). B) Quantification of
loose and dense lymphoid aggregates located in the bronchovascular area. Results are expressed as mean, n = 8 animals/group, *p < 0.05, **p
< 0.01.
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COPD, as well as the frequency and severity of COPD
exacerbations [38]. Therefore, mouse models of CS and
bacterial co-exposure have been used in the past, mainly
using Haemophilus influenzae [39]. Bacterial coloniza-
tion and infection is rare in lower airways, but not in
upper airways. Local carriage of enterotoxin-producing
S. aureus in the nasal cavity is common, although multi-
ple sites can be colonized (e.g. skin, pharynx and
perineum) [40]. These toxins, like toxic shock syndrome
toxin-1 (TSST-1), are known superantigens causing sys-
temic diseases like food poisoning and toxic shock syn-
drome [4]. In nasal polyp disease, these toxins are
believed to drive the local immunoglobulin production
in response to enterotoxin-producing S. aureus.
The use of a single toxin instead of S. aureus in this
model is both a strength and a limitation, since it
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Figure 8 Chemokines involved in the homeostatic trafficking of leukocytes. Measurements of lymphoid chemokines in lung tissue and BAL
fluid. mRNA expression of A) CXCL-13, C) CCL21-Ser, D) CCL21-Leu and E) CCL-19 in total lung tissue of mice exposed to saline or SEB,
combined with air or CS, measured by RT-PCR. The results are expressed relative to HPRT mRNA. B) Protein levels of CXCL-13 in BAL fluid as
measured by ELISA. Results are expressed as mean ± SEM, n = 8 animals/group, *p < 0.05.
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simplifies the interpretation on one hand, but is not the
real life situation on the other hand. Another limitation
is that we cannot rule out endotoxin related effects in
our model, although the LPS content of our SEB was
below detection limit. Also the potential differences
between our mouse model and the human situation
concerning exposure to bacterial toxins and its effects
on the balance of cytokines and inflammation is a lim-
itation of the study. In addition, SEB on itself has
resulted in pronounced inflammation in BAL and lungs,
as it is a known superantigen. Finally, another possible
limitation of this model is the short term (4-wk) CS
exposure, whereas COPD is a chronic disease. Despite
these limitations, altogether our findings indicate the
importance of bacterial toxins present in the upper air-
ways, affecting lower airway inflammation.
Conclusion
The possible disease-modifying role for SAEs in COPD
that has been described in humans [14], combined with
our findings stress the potential role of airway coloniz-
ing and toxin-producing Staphylococcus aureus, in the
pathophysiology of COPD [3].
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